Ankyrin repeat domain-containing protein 26 isoform 2 (168-183)

Ankyrin repeat domain-containing protein 26 isoform 2 (168-183) is a synthetic peptide fragment derived from the ankyrin repeat domain-containing protein 26, specifically encompassing amino acids 168 to 183 of the isoform 2 sequence. As a segment of a larger protein family characterized by the ankyrin repeat motif, this peptide is of significant interest in molecular biology and biochemistry due to its potential involvement in protein-protein interactions, cellular signaling pathways, and structural studies. The ankyrin repeat is a well-established protein domain known for mediating diverse interactions within the cell, and peptide fragments such as this one provide a focused tool for dissecting the functional roles of specific sequence regions within larger multidomain proteins.

Protein-protein interaction studies: The 168-183 peptide segment offers a valuable probe for investigating the mechanisms by which ankyrin repeat domains mediate specific protein-protein interactions. Researchers can utilize this peptide in binding assays, pull-down experiments, or surface plasmon resonance analyses to map interaction interfaces, assess binding affinities, and identify potential binding partners relevant to signaling or structural complexes involving the parent protein. Such studies contribute to a deeper understanding of cellular communication networks and the specificity determinants within the ankyrin repeat superfamily.

Structural biology research: Synthetic peptides corresponding to defined protein regions are frequently employed in structural and conformational analyses. The 168-183 fragment allows for detailed biophysical characterization using techniques such as circular dichroism spectroscopy, nuclear magnetic resonance (NMR), or X-ray crystallography. By examining the isolated secondary structure and folding properties of this peptide, scientists can elucidate the intrinsic conformational tendencies of the ankyrin repeat motif, which may inform the design of stabilized variants or shed light on folding intermediates relevant to the full-length protein.

Antibody epitope mapping: The defined sequence of this peptide makes it an excellent tool for epitope mapping and the development of sequence-specific antibodies. By serving as an immunogen or as a target in binding assays, the peptide enables researchers to generate and characterize monoclonal or polyclonal antibodies that recognize the 168-183 region specifically. Such antibodies are instrumental for probing the localization, expression, and post-translational modification status of ankyrin repeat domain-containing protein 26 isoform 2 in cell and tissue samples.

Peptide-based inhibitor screening: The 168-183 region may represent a functional interface or regulatory segment within the parent protein, making the synthetic peptide suitable for use in inhibitor screening assays. By competing with endogenous protein-protein interactions or serving as a template for small-molecule docking studies, the peptide can facilitate the identification and optimization of modulators that target the ankyrin repeat-mediated interactions. This approach is particularly valuable in early-stage drug discovery efforts focused on protein interaction networks.

Functional cellular assays: Incorporation of the 168-183 peptide into cellular systems, either through microinjection, transfection of peptide-conjugated constructs, or peptide delivery systems, enables researchers to probe the functional consequences of disrupting or mimicking the native protein's activity. By observing phenotypic changes, signaling alterations, or subcellular localization shifts in response to peptide treatment, scientists can gain insights into the biological roles of the ankyrin repeat domain and its contribution to cellular processes governed by protein 26 isoform 2. Such applications are critical for elucidating the mechanistic basis underlying complex cellular behaviors.

1. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

2. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

3. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

4. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

5. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide